UKSA (UK Shareholders' Association) is the oldest shareholder campaigning organisation in the UK. We are a not for profit company that represents and supports shareholders who invest in the UK stock market.

By lobbying Government, the Financial Reporting Council, the Financial Conduct Authority and other bodies we strive to continually improve recognition and treatment for private investors.



The Study's interim conclusions support many of the findings of a report submitted by UKSA to the regulator (then the FSA) five years ago. UKSA's response to the study, together with its report of 2012, can be found here .


This is a fast-growing provider of generic pharmaceutical products. From an investor’s standpoint, however, one would like to hear how the rapid increase in revenues can be turned into increased profitability by increasing Gross Margins – which is likely to mean changing the product mix, putting pressure on suppliers, increasing prices, or a mixture of all of these.


In mid-February 2017 UKSA submitted its response to the government’s Green Paper on corporate governance to the Department for Business, Energy and Industrial Strategy (BEIS). The response to the Green Paper was developed jointly with ShareSoc. The full Green Paper response can be read here .

UKSA and ShareSoc also submitted a covering letting with their Green paper response. The covering letter was designed to draw the attention of BEIS to wider executive pay and corporate governance issues which were not prompted by the Green Paper. UKSA’s covering letter can be read here .


Better Finance, the European umbrella body of which UKSA is a member, commissioned a major study to identify potential falsely active funds (“closet indexers”) and is calling on regulators to investigate.


This long-established family firm has a reputation for good management. The balance sheet looks exceptionally strong with cash and debtors of £78m and current liabilities of just £26m, which includes a £25m pension deficit. But is the financial management of the company too conservative or is it an excellent investment for investors who like to sleep easily at night?


Syndicate content